Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma
Yahaya A Yabo, Simone P. Niclou, Anna Golebiewska
Neuro-Oncology (2021) Vol. 24, Iss. 5, pp. 669-682
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Spatial cellular architecture predicts prognosis in glioblastoma
Yuanning Zheng, Francisco Carrillo‐Pérez, Marija Pizurica, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives
Ilaria Salvato, Antonio Marchini
Cancers (2024) Vol. 16, Iss. 7, pp. 1276-1276
Open Access | Times Cited: 14
Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features
Alberto Ballestín, Daniele Armocida, Valentino Ribecco, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Intercellular Communication in the Brain through Tunneling Nanotubes
Khattar E. Khattar, Janice Safi, Anne‐Marie Rodriguez, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1207-1207
Open Access | Times Cited: 35
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma
Kelly Mitchell, Samuel A. Sprowls, Sonali Arora, et al.
Genes & Development (2023) Vol. 37, Iss. 3-4, pp. 86-102
Open Access | Times Cited: 28
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
Yahaya A Yabo, Pilar M. Moreno‐Sanchez, Yolanda Pires‐Afonso, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 11
GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression
Chaolong Yan, Zijiang Yang, Pin Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Signaling, cancer cell plasticity, and intratumor heterogeneity
Marco Cordani, Ilaria Dando, Giulia Ambrosini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma
Xiaoteng Cui, Dawei Huo, Qixue Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
A fractional mathematical model approach on glioblastoma growth: tumor visibility timing and patient survival
Nurdan Kar, Nuri Özalp
Mathematical Modelling and Numerical Simulation with Applications (2024) Vol. 4, Iss. 1, pp. 66-85
Open Access | Times Cited: 6
The impact of ATP-binding cassette transporters in the diseased brain: Context matters
Chrysiida Baltira, Eleonora Aronica, William F. Elmquist, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101609-101609
Open Access | Times Cited: 6
It’s all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma
Rebeca Yakubov, Ramneet Kaloti, Phooja Persaud, et al.
Journal of Neuro-Oncology (2025)
Open Access
Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted Treatment
Liyin Wang, Min Gu, Xiaoli Zhang, et al.
Advanced Science (2025)
Open Access
Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions
Brandon Bumbaca, Jonah R. Huggins, Marc R. Birtwistle, et al.
npj Systems Biology and Applications (2025) Vol. 11, Iss. 1
Open Access
EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes
Ranim El Baba, Sébastien Pasquereau, Sandy Haidar Ahmad, et al.
Oncogene (2023) Vol. 42, Iss. 24, pp. 2031-2045
Open Access | Times Cited: 18
Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach
Amir Barzegar Behrooz, Hamid Latifi‐Navid, Simone C. da Silva Rosa, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3158-3158
Open Access | Times Cited: 17
Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains
Joel J.D. Moffet, Oluwaseun E. Fatunla, Lutz Freytag, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 16
Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock
Nina Nelson, Angela Relógio
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Emerging Therapies for Glioblastoma
Stella Rios, Stephanie Oyervides, David Uribe, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1485-1485
Open Access | Times Cited: 5
Understanding glioblastoma at the single-cell level: Recent advances and future challenges
Yahaya A Yabo, Dieter Henrik Heiland
PLoS Biology (2024) Vol. 22, Iss. 5, pp. e3002640-e3002640
Open Access | Times Cited: 5
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba Ali, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1354-1375
Open Access | Times Cited: 5
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance
Cathy Pichol-Thievend, Océane Anezo, Aafrin M. Pettiwala, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms
Filippo Torrisi, Simona D’Aprile, Simona Denaro, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 220-220
Open Access | Times Cited: 13
SEC61G assists EGFR -amplified glioblastoma to evade immune elimination
Kunlin Zeng, Yu Zeng, Hongchao Zhan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 32
Open Access | Times Cited: 13
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers
Ioannis Ntafoulis, Anne Kleijn, Jie Ju, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 8, pp. 1327-1338
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top